Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Which Low Fee Index Funds Offer Best Value 2024 compares low-cost funds to help you pick the best value for retirement goals.
27,292 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
A sweeping study finds AI financial tools may simulate emotional states, including addiction-like responses and dread...
Chipotle stock could see meaningful upside as management advances a multi-year expansion plan and digital push, even ...
JPMorgan boosted Hewlett Packard Enterprise's price target to $37, citing easing memory costs and improving earnings ...
A November-like standoff erupts as MRED suspends Zillow’s access to Chicagoland listing data, potentially reshaping h...
BitMine Immersion Technologies’ largest ETH purchase of the year lifts holdings to about 5.39 million ETH, reinforcin...
erin brockovich, activist defeated, pivots from courtroom wins to data-center transparency, unveiling a nationwide re...
A hypothetical 60-year-old couple with $2.8 million could retire by the end of 2027 if they cap taxable withdrawals d...
Nightrush.com announces a major editorial and platform revamp to match AI-driven personalization in iGaming, with a f...
Nvidia CEO Jensen Huang spoke on AI’s societal impact and the politics surrounding it, highlighting how leadership, p...
Palantir tumbles about 7% midday as Palo Alto Networks and CrowdStrike hold steadier, raising questions about governm...
SharpLink Gaming resumes ETH purchases after eight months, fueling a renewed ethereum price prediction: forgotten con...